Alpine Immune Sciences Inc (ALPN)
Market Closed
17 May, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
SIX $
64. 97
+0.01
+0.0154%
$
4.46B Market Cap
- P/E Ratio
- Div Yield
4.29M Volume
-1.08 Eps
$ 64.96
Previous Close Want to track ALPN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.12 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ALPN Earnings Reports FAQ
What is the earnings per share (EPS) for ALPN?
The current EPS is -1.08.
What is the company's earnings growth rate?
Alpine Immune Sciences Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Alpine Immune Sciences Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Alpine Immune Sciences Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ALPN at this time, as Alpine Immune Sciences Inc has no recent EPS data to calculate it.
